Skip to content

Clinical trials

Completed Phase 2 Autoimmune Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Status: Completed Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20032
20041
20056
20063
20082
20092
20103
20114
20122
20134
20151
20163
20171
20181
20192
20205
20213
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)7
Novartis Pharmaceuticals3
Anthera Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris2
AstraZeneca2
Diamyd Therapeutics AB2
National Institute of Allergy and Infectious Diseases (NIAID)2
National Institute of Dental and Craniofacial Research (NIDCR)2
Northwestern University2
University of Colorado, Denver2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases57
Arthritis, Rheumatoid8
Lupus Erythematosus, Systemic7
Thrombocytopenia7
Anemia, Aplastic6
Diabetes Mellitus, Type 16
Immune System Diseases6
Diabetes Mellitus5
Sjogren's Syndrome5
Inflammation4

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.